These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 22139111)

  • 1. [Towards more appropriate drug use?].
    Beiske G
    Tidsskr Nor Laegeforen; 2011 Nov; 131(23):2341. PubMed ID: 22139111
    [No Abstract]   [Full Text] [Related]  

  • 2. [A small, corrupt old service--pharmacies and pharmacy law 2001].
    Hamran O
    Tidsskr Nor Laegeforen; 2011 Jul; 131(13-14):1311-5. PubMed ID: 21725395
    [No Abstract]   [Full Text] [Related]  

  • 3. [Parallel import of drugs for better and for worse].
    Krabbe U
    Ugeskr Laeger; 2004 Feb; 166(7):611. PubMed ID: 15005051
    [No Abstract]   [Full Text] [Related]  

  • 4. Plans confront specialty pharmacy's escalating costs in variety of ways.
    Reinke T
    Manag Care; 2010 Dec; 19(12):12-3, 15-6, 19. PubMed ID: 21291126
    [No Abstract]   [Full Text] [Related]  

  • 5. Descriptive tools and analysis.
    Capellà D
    WHO Reg Publ Eur Ser; 1993; 45():55-78. PubMed ID: 8442851
    [No Abstract]   [Full Text] [Related]  

  • 6. The top 50 prescription medications dispensed in pharmacies in 2003.
    Wynn RL
    Gen Dent; 2004; 52(6):484-7. PubMed ID: 15636268
    [No Abstract]   [Full Text] [Related]  

  • 7. [Who is responsible when the profit is low?].
    Hammerstrøm J
    Tidsskr Nor Laegeforen; 2003 Nov; 123(22):3177. PubMed ID: 14714000
    [No Abstract]   [Full Text] [Related]  

  • 8. [Misleading assessment--8 out of 10 (not 4 out of 10) return unused drugs to pharmacies!].
    Ekedahl A
    Lakartidningen; 2004 May; 101(19):1744; author reply 1744. PubMed ID: 15188596
    [No Abstract]   [Full Text] [Related]  

  • 9. [900 tons of drugs are returned to pharmacies annually. A questionnaire study on unused drugs].
    Asberg KH
    Lakartidningen; 2004 Mar; 101(10):898-900. PubMed ID: 15055052
    [No Abstract]   [Full Text] [Related]  

  • 10. Drugs still influence health costs, but trend abating.
    Capitation Rates Data; 2003 Oct; 8(10):114-20. PubMed ID: 14621548
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-Glaxo campaign heats up in United States.
    Moynihan R
    BMJ; 2003 Feb; 326(7386):413. PubMed ID: 12595358
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacies before and after the new legislation].
    Lange MH; Granås AG
    Tidsskr Nor Laegeforen; 2003 Nov; 123(22):3248-9. PubMed ID: 14714022
    [No Abstract]   [Full Text] [Related]  

  • 13. Revolving drug funds: a step towards health security.
    Umenai T; Narula IS
    Bull World Health Organ; 1999; 77(2):167-71. PubMed ID: 10083717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Creating reliable pharmaceutical distribution networks and supply chains in African countries: Implications for access to medicines.
    Tetteh E
    Res Social Adm Pharm; 2009 Sep; 5(3):286-97. PubMed ID: 19733829
    [No Abstract]   [Full Text] [Related]  

  • 15. US buyers of drugs from Canadian pharmacies face prosecution.
    Spurgeon D
    BMJ; 2003 Mar; 326(7390):618. PubMed ID: 12649223
    [No Abstract]   [Full Text] [Related]  

  • 16. [Influence of the reimbursement scheme on the consumption of drugs].
    Madsen UK
    Ugeskr Laeger; 2009 Mar; 171(10):783-6. PubMed ID: 19265600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NerveCenter: Sumatriptan's evolution from brand drug to best buy of 2010.
    Stone K
    Ann Neurol; 2010 Sep; 68(3):A10-1. PubMed ID: 20818778
    [No Abstract]   [Full Text] [Related]  

  • 18. Entry of new pharmacies in the deregulated Norwegian pharmaceuticals market--consequences for costs and availability.
    Rudholm N
    Health Policy; 2008 Aug; 87(2):258-63. PubMed ID: 18164509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Deregulation of the pharmacy monopoly--learn from Norway].
    Overby A
    Lakartidningen; 2007 Sep 26-Oct 2; 104(39):2820. PubMed ID: 17958010
    [No Abstract]   [Full Text] [Related]  

  • 20. [Returned medicines as quality indicator for pharmacotherapy--what is left?].
    Thormodsen M; Fonneløp H; Rytter E; Tørisen HM
    Tidsskr Nor Laegeforen; 1997 Oct; 117(24):3517-20. PubMed ID: 9411912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.